Integra Lifesciences Holdings (IART) Shares Outstanding (2009 - 2026)

Integra Lifesciences Holdings has reported Shares Outstanding (Entity) for 18 years, with the latest figure at $92.1 million in Q2 2026.

• Quarterly Shares Outstanding (Entity) rose 20.13% year-over-year to $92.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $92.1 million (up 20.13% YoY) and the FY2025 annual result came in at $76.7 million, down 16.31% from the prior year.
• Shares Outstanding (Entity) steadied at $92.1 million in Q2 2026 per IART's latest filing, from $92.2 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $92.2 million in Q1 2026 and troughed at $200000.0 in Q1 2022.
• A 5-year average of $58.7 million and a median of $83.5 million in 2022 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) surged 30394.67% in 2024, then slumped 98.25% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $90.5 million in 2022, then rose by 0.49% to $90.9 million in 2023, then climbed by 0.76% to $91.6 million in 2024, then declined by 16.31% to $76.7 million in 2025, then gained by 20.16% to $92.1 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $92.1 million, $92.2 million, and $76.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.